BMI View: Malaysia’s pharmaceuticals and healthcare market continues to grow, and government support to both the industry and the roll out of universal healthcare means that its growth prospects are good throughout the course of our 10 year forecast period. While communicable diseases have historically defined the burden of disease, lifestyle changes and an expanding middle class mean that noncommunicable diseases are now gaining prominence. The country is also gaining an important reputation as a hub for medical tourism, although problems, in terms of shortages of healthcare personnel, remain. Headline Expenditure Projections ? Pharmaceuticals: MYR6.06bn (US$1.96bn) in 2012 to MYR6.5bn …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=118171.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/malaysia-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.
No comments:
Post a Comment